SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008476
Filing Date
2022-05-09
Accepted
2022-05-09 16:04:05
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20220331.htm   iXBRL 10-Q 2250497
2 EX-10.2 igms-ex10_2.htm EX-10.2 157408
3 EX-31.1 igms-ex31_1.htm EX-31.1 18726
4 EX-31.2 igms-ex31_2.htm EX-31.2 17145
5 EX-32.1 igms-ex32_1.htm EX-32.1 11095
6 EX-32.2 igms-ex32_2.htm EX-32.2 11090
  Complete submission text file 0000950170-22-008476.txt   7330951

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20220331_pre.xml EX-101.PRE 352372
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igms-20220331_cal.xml EX-101.CAL 47311
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20220331.xsd EX-101.SCH 56721
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igms-20220331_def.xml EX-101.DEF 234834
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20220331_lab.xml EX-101.LAB 454284
56 EXTRACTED XBRL INSTANCE DOCUMENT igms-20220331_htm.xml XML 1019002
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 22904824
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences